The approval of exenatide 1.2 mL and 2.4 mL prefilled pen injection, referencing BYETTA®, reflects the Company’s deep innovation and regulatory capabilities in complex pharmaceuticals and its ...

Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.

Amneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE) prefilled syringe ...